Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study).

Auerswald, Guenter; Djambas Khayat, Claudia; Stasyshyn, Oleksandra; Iosava, Genadi; Romashevskaya, Irina; López, Marta Julia; Seifert, Wilfried; Rogosch, Tobias

Auerswald, Guenter; Djambas Khayat, Claudia; Stasyshyn, Oleksandra; Iosava, Genadi; Romashevskaya, Irina; López, Marta Julia; Seifert, Wilfried; Rogosch, Tobias.

Afiliação

Auerswald G; Hess Kinderklinik, Klinikum Bremen-Mitte, Bremen, Germany.
Djambas Khayat C; Hotel Dieu de France Hospital, St Joseph University, Beirut, Lebanon.
Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine, Academy of Medical Sciences of Ukraine, Lviv, Ukraine.
Iosava G; Institute for Hematology and Transfusiology, Tbilisi, Georgia.
Romashevskaya I; Republican Research Centre for Radiation Medicine and Human Ecology, Gomel, Belarus.
López MJ; Hematology, Hospital Roosevelt, Guatemala, Guatemala.
Seifert W; Clinical Development, CSL Behring, Marburg, Germany.
Rogosch T; Clinical Development, CSL Behring, Marburg, Germany.

J Blood Med ; 11: 213-225, 2020.

Article em En | MEDLINE | ID: mdl-32607039

Palavras-chave

clinical trial; pediatrics; prophylaxis; von Willebrand disease; von Willebrand factor-factor VIII concentrate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha